Pacira BioSciences (PCRX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec2

Pacira Pharmaceuticals Study: iovera° Cryoneurolysis More Effective Than Radiofrequency Ablation for Chronic Lower Back Pain

13:01

Nov19

Pacira BioSciences Inc. CMO Jonathan Slonin Reports Sale of Common Stock

21:32

Nov17

H.C. Wainwright Analyst Grants Pacira Pharmaceuticals a Buy Rating

11:31

Nov11

DOMA calls for internal changes at Pacira

01:32

Nov10

RBC Capital Analyst Maintains Hold Rating on Pacira Pharmaceuticals

12:26

Nov7

Needham analyst maintains buy rating on Pacira Pharmaceuticals

12:12

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 179.52 M, Net Income 5.432 M, EPS 0.12

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 181.1 M, Net Income -4.847 M, EPS -0.11

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 168.92 M, Net Income 4.812 M, EPS 0.1

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More